CellSource Co.,Ltd. [4880.T]

TOKYO, May 14 (Pulse News Wire) – Cellsource CO.,LTD. (4880.T) reported its April performance metrics for its processing service, showing a slight decline compared to the same period last year.

The average daily number of processed orders was 56.5, slightly below the previous year's figure of 58. Among specialties, orthopedic services focused on self-pay treatments saw a significant drop of 235 orders, while hybrid orthopedics increased by 164 orders and obstetrics-gynecology and aesthetics each rose by 30 and 12 orders respectively. In detail, the company noted that despite ongoing efforts to strengthen support systems through healthcare institution management assistance programs, the number of orders for self-pay-focused orthopedic services decreased by 27.7%. Conversely, hybrid orthopedic services experienced a boost due to promotional activities, achieving their highest level ever at 847 orders, up by 24.0%.

Obstetric-gynecological services saw a modest increase of 30 orders, marking a rise of 31.9%, while aesthetic services grew by 12 orders, representing a 133.3% increase. Regarding the two customer groups, Group 1, which comprises key clients contributing significantly to sales, witnessed a reduction of 149 orders compared to the same period last year, largely attributed to pre-ordering effects from October initiatives. However, Group 2, consisting of non-core medical institutions and newly affiliated ones, showed substantial growth with an additional 605 orders, reflecting a strategy shift implemented this quarter. Overall, the company continues to focus on expanding its reach among hybrid medical facilities.

Original Disclosure (PDF)

🟢 Confidence: High AI-translated content.